The human liver possesses a remarkable capacity to restore itself. After a portion is donated, the remaining liver can expand to its original size and function within months, and liver injuries often heal without leaving scar tissue. This regenerative prowess is unusual compared to most other adult organs, which accumulate irreversible damage when injured. For example, kidneys slowly decline with age, neurons do not replace lost cells, and heart muscle does not regenerate after childhood.
A central explanation offered by the article links regeneration to cancer risk through the behavior of telomeres. Telomeres shorten with each cell division, eventually halting proliferation—a process that acts as a brake on uncontrolled growth. The article argues that allowing telomeres to erode is a deliberate design choice: it limits the ability of pre‑cancerous cells to accumulate enough divisions to become dangerous tumors, even though it also contributes to aging and tissue frailty. Organs that face frequent mutagenic challenges, like the liver, are thus expected to evolve higher regeneration despite the accompanying rise in cancer susceptibility, while organs that are less exposed to such stresses can afford to be more fragile because the cancer trade‑off is less advantageous.
However, the article also highlights important caveats to this simple trade‑off view. Highly structured organs such as the heart or brain may not be able to regenerate even if doing so would reduce cancer risk, because their complex circuitry could be disrupted by new cell growth. The lungs illustrate another nuance: their intricate fractal surface area, needed for efficient gas exchange, makes regeneration difficult, yet they still encounter many airborne carcinogens, resulting in both low regeneration and high cancer risk. The pancreas further complicates the pattern, showing moderate cancer risk despite limited regeneration and limited exposure to external toxins, suggesting that additional, poorly understood factors may be at play.